Actyon Discovery, Inc. (“Actyon”, https://actyondiscovery.com) is a seed-stage digital drug discovery company focused on the design, validation, and delivery of novel scaffold based small molecule drug candidates to drug development partners. Actyon is based in San Diego, USA.
Claim-Staking in IP-Free Drug Space: Actyon discovers intellectual property free (IP-Free) novel drug scaffolds from unexplored chemistry spaces.
The Actyon drug discovery approach employs the creation of ultra-large virtual libraries containing billions of newly discovered synthetically accessible drug-like molecules. These unexplored chemistry spaces are analyzed for novel chemistry classes based on innovative IP-free scaffolds. AI based tools are used to identify molecules likely to interact with selected drug targets.